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ABSTRACT 
Background: Patients who experience pain, swelling, and trismus after 
third-molar extraction are reported to experience a 3-fold higher rate of ad- 
verse effects (AEs) on quality of life compared with those who are asympto- 
matic after this surgery. Therefore, investigators emphasize the necessity for 
better control of this triad of sequelae. Steroids can reduce the risk for physi- 
ologic processes of inflammation, thereby suppressing the development of 
inflammation. 
Objective: The aim of this study was to compare the effects of dexametha- 
sone 8 mg IM and diclofenac potassium 04) 50 mg PO, dexamethasone 8 mg IM 
and acetaminophen 1000 mg PO, and monotherapy with diclofenac K 50 mg PO on 
postoperative pain, swelling, and trismus after surgical removal of third molars. 
Methods: This prospective, randomized, open-label pilot study was con- 
ducted at the Department of Oral and Maxillofacial Surgery, Lagos University 
Teaching Hospital, Lagos, Nigeria. Patients were randomly allocated to 1 of 
3 treatment groups: concomitant treatment with dexamethasone 8 mg IM and 
diclofenac K 50 mg PO or acetaminophen 1000 mg PO, or monotherapy with 
diclofenac K 50 mg PO. Overall analgesic efficacy of the drug combinations was 
assessed for 7 days postoperatively using a 4-point categorical pain-intensity 
rating scale (0 = no pain; 1 = mild pain; 2 = moderate pain; and 3 = severe pain). 
Accepted for publication May 30, 2006. 
Reproduction in whole or part is not permitted. 
doi:l 0.1016/j.curtheres.2006.07.001 
0011-393X/06/$19.00 
Copyright © 2006 Excerpta Medica, Inc. 229 
CURRENT THERAPEUTIC RESEARCH 
Facial swelling was measured in 1 dimension on days 1, 2, and 7 after surgery 
using a tape measure placed from the tip of the tragus, to gonion, to the tip of 
the contralateral tragus, and trismus was assessed using interincisal mouth- 
opening ability, measured using a vernier-calibrated caliper on postoperative 
days 1, 2, and 7. Tolerability was assessed using direct questioning of the pa- 
tients at follow-up visits. 
Results: A total of 150 patients (50 per treatment group) were included in the 
analysis (76 women, 74 men; mean [SD] age, 26.8 [5.04] years [range, 18- 
45 years]; 100% Nigerian). The proportion of patients reporting no pain on the 
pain-intensity rating scale was significantly higher in the group receiving dexa- 
methasone and diclofenac K compared with that in the groups receiving dexa- 
methasone and acetaminophen or diclofenac K monotherapy (44% vs 22% and 
24%, respectively; both, P < 0.05). Facial swelling was significantly less with dexa- 
methasone and diclofenac K or dexamethasone and acetaminophen compared 
with diclofenac K alone (day 1: P = 0.013 and P = 0.011, respectively; day 2: P = 
0.002 and P = 0.004, respectively). However, trismus relief was statistically simi- 
lar between the 3 treatment groups on postoperative days 1 and 2. No AEs or 
complications were recorded. 
Conclusion: In this open-label pilot study, concomitant treatment with dex- 
amethasone and diclofenac K provided significant relief of postsurgical pain 
and swelling compared with dexamethasone and acetaminophen or monother- 
apy with diclofenac K after third-molar extraction in these patients. (Curr Ther 
Res Clin Exp. 2006;67:229-240) Copyright © 2006 Excerpta Medica, Inc. 
Key words: dexamethasone, diclofenac potassium, acetaminophen, third- 
molar extraction. 
INTRODUCTION 
Surgical removal of impacted third molars is a common outpatient procedure 
in oral surgery. I It has been documented that extraction of impacted teeth 
results in severe postoperative pain, swelling, and trismus in most cases. 2
Patients who experience these sequelae are reported to have a 3-fold higher 
rate of adverse ffects (AEs) on quality of life compared with patients who do not. 2 
Pharmacologically controlling the extent of the inflammatory process can de- 
crease the intensity of this triad of sequelae of tissue trauma. 3-5 Oral surgeons 
have traditionally prescribed corticosteroids, NSAIDs, and narcotic analgesics 
to manage these 3 sequelae. 3 
One technique for reducing the postoperative inflammatory process is the 
administration of corticosteroids, 4 such as cortisol and the synthetic analogue 
of cortisol, which have been found to suppress the physiologic processes of 
local heat, redness, swelling, and tenderness that characterize inflammation. 4 
Although both short-term and single-dose corticosteroid treatment have been 
found effective in reducing postoperative inflammation, 5,6 many clinicians are 
reluctant o use corticosteroids in conjunction with oral surgery because of 
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concerns about possible AEs, primarily infection and adrenal suppression, 5,6 
even though the latter has been found to occur only with long-term administra- 
tion. 6 The corticosteroid dexamethasone, one of the potent synthetic analogues 
of cortisol, has predominantly anti-inflammatory effects. 7 Its main clinical appli- 
cation is as a steroidal anti-inflammatory agent, with effects on metabolism, 
water and electrolyte balance, negative feedback on the hypothalamus and 
pituitary, and anti-inflammatory and immunosuppressive effects. 6,7 
Another technique is the administration of NSAIDs, which block the arachi- 
donic acid cascade, thereby inhibiting the activity of the cyclooxygenase (COX) 
enzyme system, which, in turn, reduces the biosynthesis of the prostaglandins 
(eg, PgF 2, PgE~) 2,3 that play a major role in causing pain, inflammation, and fever. 2,3 
When NSAIDs are administered before surgery, their absorption and distribu- 
tion can occur before the initiation of tissue trauma, the ensuing synthesis of 
prostaglandins, and the subsequent inflammatory response. 3 NSAlDs have been 
found to be particularly effective in combating postoperative pain, 2,3 including 
pain after oral surgery. 1,3 Diclofenac potassium (K), a potent NSAID, has been 
shown to be useful in controlling pain after the removal of third molars. 7Like 
other NSAIDs, diclofenac inhibits COX activity by reducing the production of 
prostaglandins in tissue. However, diclofenac has been associated with gastric 
erosion and prolonged bleeding time. 8,9 Thus, it is preferable to avoid prescrib- 
ing diclofenac in patients with current or a history of peptic ulceration, and to 
discontinue treatment with the drug if gastrointestinal lesions develop. 9 
Although the usual approach in studies of the analgesic effects of NSAlDs has 
been to compare the effects of _>2 NSAiDs, 8 based on a MEDLINE search (key 
terms: clinical trials, third molar, surgery, and adverse effects; years: 1982-2000), 
many studies have compared the efficacy of NSAlDs with that of acetamino- 
phen. 6,7,9-16 Analysis of the results showed no statistical differences between 
the active-treatment groups and NSAIDs and acetaminophen. 6,7,9-12 Seymour et 
a113 found that single-dose ketoprofen (12.5 and 25 mg) and acetaminophen 
were effective in treating pain after third-molar extraction. Acetaminophen has 
analgesic and antipyretic effects similar to aspirin. However, it has only weak 
anti-inflammatory effects and is thought to have a generally poor ability to 
inhibit the activity of the COX enzyme system in the presence of high concen- 
trations of peroxidases, as are found at sites of inflammation. 17
The addition of dexamethasone, a synthetic adrenocortical steroid, to a regimen 
containing diclofenac K or acetaminophen might have additive anti-inflammatory 
effects, thereby reducing the inflammatory exudates, with resultant further 
reduction in edema nd pain, after third-molar extraction. However, data compar- 
ing the effects of dexamethasone coadministered with diclofenac K or acetamin- 
ophen and diclofenac K monotherapy are lacking, and this was the reason for our 
study. 
This study assessed the effects of combination treatment with dexamethasone 
and diclofenac K or acetaminophen with those of diclofenac K alone on postop- 
erative pain, swelling, and trismus after surgical removal of third molars. 
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PATIENTS AND METHODS 
This prospective, randomized, open-label pilot study was conducted at the De- 
partment of Oral and Maxillofacial Surgery, Lagos University Teaching Hospital, 
Lagos, Nigeria. The study protocol was approved by the research and ethics 
committee of the hospital. The study was conducted in accordance with the 
principles of the Guideline for Good Clinical Practice 18 and Declaration of 
Helsinki of the World Medical Association and its amendments. 19 
Inclusion and Exclusion Criteria 
Patients between 18 and 45 years of age presenting in 2003-2004 to the Oral 
and Maxillofacial Surgery Clinic at the Lagos University Teaching Hospital and 
scheduled for surgical removal of a unilateral or bilateral bone-impacted 
mandibular third molar under local anesthesia were included. Before the study, 
full medical history was obtained from all patients. 
Patients with renal or hepatic disease; blood dyscrasia; history or presence 
of gastric ulcers; cardiovascular disease; known hypersensitivity, allergy, or his- 
tory of idiosyncratic reaction, to any of the study medications; and/or who were 
pregnant or breastfeeding were excluded from the study. Patients who had 
received analgesics or anti-inflammatory drugs within 24 hours before surgery 
were also excluded from the study. Patients with pain and/or other inflamma- 
tory symptoms (eg, swelling, hyperemia, decreased mouth-opening due to tris- 
mus) at the time of surgery were excluded. 
The study protocol was explained to the patients in detail, after which writ- 
ten, informed consent was obtained. 
Study Drug Administration 
Patients were randomly allocated to 1 of 3 treatment groups, as follows. Color 
codes were placed in sealed envelopes. The color code selected by the patient rep- 
resented the treatment group into which he or she was allocated. Interpretation f 
the color codes was disclosed only to the surgeon on completion of the study. This 
method of randomization has not been validated. One group was assigned to 
receive concomitant treatment with dexamethasone 8 mg IM and diclofenac K
50 mg PO. Another group of patients was concomitantly administered dexametha- 
sone 8 mg PO and acetaminophen 1000 mg PO, and a third group comprised 
patients administered diclofenac K 50 mg PO. Dexamethasone was administered 
30 minutes before and 6 and 12 hours after surgery. Diclofenac K was administered 
30 minutes before and BID for 5 days after surgery. Acetaminophen was adminis- 
tered 30 minutes before and TID for 5 days after surgery. During the hospital stay, 
all study medications were administered by a nurse. Compliance was assessed 
using a pill count for medications administered after hospital discharge. 
Patients were instructed to request additional analgesia in the event of an 
aggravated pain episode during the study. The use of additional analgesia was 
considered a withdrawal criterion a priori, and these patients were excluded 
from the data analysis. 
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Surgical Procedures 
The degree of surgical difficulty was assessed using Winter's and Terence Ward 
lines and Pell-Gregory criteria. 2° Oral antibiotics (500 mg ampicillin/cloxacillin 
and 400 mg metronidazole) were administered to all patients 30 minutes before 
surgery. After surgery, patients received a 5-day antibiotic regimen (500-mg 
ampicillin/cloxacillin every 6 hours and 400 mg metronidazole every 8 hours). 
After adequate levation and reflection of the buccal mucoperiosteal flap 
with the patient under local anesthesia (2% lignocaine hydrochloride with 
adrenaline 1:100,000), surgical extraction of the third molar was carried out 
using the buccal guttering technique. Tooth removal was followed by meticu- 
lous irrigation of the surgical area with isotonic saline (0.9%). The 3-sided 
mucoperiosteal flap was repositioned and sutured. A single surgeon (B.O.B.) 
performed all of the surgical procedures. 
Efficacy Assessments 
Pain Intensity 
Preoperative pain intensity was assessed using a 4-point Likert-type cate- 
gorical rating scale (0 = no pain [no discomfort]; 1 = mild [almost unnotice- 
able]; 2 = moderate [noticeable, but patient can still engage in activities of 
daily living (ADLs)]; and 3 -- severe [very noticeable and disrupts ADLs]). 6,21 
Pain intensity was recorded in a pain-assessment diary by the surgeon once 
daily during the first 2 days after surgery, and by the patient once daily for the 
remaining 5 days of observation. Before patients were discharged, the surgeon 
ensured they were thoroughly instructed on how to complete the pain self- 
assessment diary and when and how to self-administer medications. 
Facial Swelling 
Assessment of facial swelling resulting from surgical procedures has 
proved problematic because swelling involves a 3-dimensional volumetric 
change at the tissue and cellular levels. 22 Several methods are used to assess 
facial swelling. These include photographic analysis, modified face bowl, lin- 
ear measurements, and subjective assessment. 22 No technique has been 
proven more accurate than others in analyzing facial swelling. We used a tape 
measure (Superior tailoring rule, Butterfly, Shanghai, China) to assess facial 
swelling in 1 dimension: from the tip of tragus of the left ear, to the gonion, 
to the tip of tragus of the right ear. The mean of 3 measurements was used. 
The same tape measure was used in all patients. Facial width was measured 
just before surgery (baseline) and on postoperative days 1, 2, and 7, and 
facial swelling was expressed as the percentage increase from baseline in 
facial width. 
Trismus 
A vernier-calibrated sliding caliper placed on the incisal edge of the maxil- 
lary and mandibular central incisors was used to record maximum interincisal 
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mouth-opening. The mean of 3 measurements was used. Mouth-opening was 
assessed just before surgery and on days 1, 2, and 7 after surgery. Postoperative 
trismus was expressed as the percentage decrease from baseline in mouth-opening. 
Tolerability 
Patients were specifically questioned about AEs by the surgeon at follow-up 
appointments. Follow-up appointments were scheduled for once daily in the 
morning on postoperative days 1 to 5. 
Statistical Analysis 
The required sample size (50 patients per group) to determine significant 
between-group differences in mean postoperative pain-intensity score, facial 
swelling, and maximum interincisal mouth-opening was calculated using a pre- 
viously validated formula. 6,23 Descriptive statistics, 1-way analysis of variance, 
the t test, and the 22 test were used to compare facial swelling, pain intensity, 
and mouth-opening. Data were analyzed using SPSS version 11.5 (SPSS Inc., 
Chicago, Illinois). Statistical significance was set at P < 0.05. 
RESULTS 
Study Population 
A total of 155 patients were originally recruited. Alveolar osteitis developed 
in 3 patients (2 women, 1 man) 2 days after surgery, and severe pain requiring 
use of additional analgesics developed in 2 patients (acetaminophen group) on 
postoperative day 1; these patients were excluded from the final analysis. Thus, 
150 patients were included in the data analysis (76 women, 74 men; mean [SD] 
age, 26.8 [5.04] years [range, 18-45 years]; 100% Nigerians; 50 patients per 
group). The male-to-female ratio was 1:1.02. The radiographic analysis of the 
types of impactions showed that mesioangular impaction constituted 79 
(52.7%) cases, followed by distoangular impaction in 30 (20.0%) (Table I). The 
mean total operation time was 39.4 minutes, while the mean bone operating 
time was 17.10 minutes. No statistically significant differences were observed in 
the mean total operation time between the 3 groups. 
Efficacy 
Pain Intensity 
The proportion of patients reporting no pain on postoperative day 1 was 
significantly greater in the group receiving concomitant treatment with dexa- 
methasone and diclofenac K compared with those receiving dexametha- 
sone and acetaminophen or diclofenac K monotherapy (both, P < 0.05) 
(Table II). Rates of mild to moderate and severe pain were statistically simi- 
lar between the 3 treatment groups. By the third day after surgical extrac- 
tion, no detectable differences in pain intensity were observed between the 
3 groups. 
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Table I. Baseline characteristics of the study patients. *t 
Dexamethasone Dexamethasone 
and and 
Diclofenac K Acetaminophen Diclofenac K All Patients 
Characteristic (n = 50) (n = 50) (n = 50) (N = 150) 
Age, y 
Mean (SD) 25.6 (4.8) 27.6 (5.3) 27.2 (5.1) 26.8 (5.04) 
Range 17-46 16-47 19-44 18-45 
Sex, no. (%) 
Male 25 (56) 28 (56) 24 (48) 74 (49) 
Female 22 (44) 22 (44) 26 (52) 76 (51) 
Nigerian race, 
no. (%) 50 (I00) 50 (I 00) 50 (I 00) 150 (I 00) 
Impaction type, 
no. (%) 
Mesioangular 28 (56) 25 (50) 26 (52) 79 (53) 
Distoangular 12 (24) I 0 (20) 8 (I 6) 30 (20) 
Horizontal 6 (12) 7 (14) 10 (20) 23 (15) 
Vertical 4 (8) 8 (16) 6 (12) 18 (12) 
Duration of surgery, 
mean (SD), mln 
Bone 20.78 (9.69) 13.08 (7.53) 17.44 (10.69) 1 7.10 (9.86) 
Total 41.30 (12.65) 38.48 (13.44) 38.26 (14.71 ) 39.35 (13.61 ) 
K = potassium. 
*No significant between-group differences were found. 
tAIthough some patients underwent extraction of >1 tooth, only 1 tooth per patient was included in 
the analysis. 
Facial Swelling and trismus 
Table II also shows data concerning facial swelling and maximal mouth- 
opening on postoperative days 1 and 2. Patients administered dexamethasone 
and diclofenac K or acetaminophen had significantly less postoperative facial 
swelling compared with the group receiving diclofenac K monotherapy (day 1: 
P = 0.013 and P = 0.011, respectively; day 2" P = 0.002 and P = 0.004, respectively), 
suggesting that dexamethasone was associated with a significant reduction 
in facial swelling. No statistically significant differences in trismus were found 
between the 3 groups on postoperative days 1 and 2. By day 7 after surgical 
extraction, o detectable differences in facial swelling or trismus were observed 
between the 3 groups. 
Tolerabi l i ty  
No AEs or complications were recorded. Postoperative healing proceeded 
normally in all patients, and no increased tendency for intraoperative or post- 
operative bleeding was recorded. 
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Table II. Pain intensity, facial swelling, and mouth-opening ability at postsurgical days 
1 and 2.* 
Dexamethasone Dexamethasone 
and and 
Diclofenac K Acetaminophen Diclofenac K 
Parameter (n = 50) (n = 50) (n = 50) 
Day-1 pain intensity, 
no. (%) 
None 22 (44) t 11 (22) 12 (24) 
Mild 25 (50) 32 (64) 23 (46) 
Moderate 3 (6) 7 (14) 11 (22) 
Severe 0 0 4 (8) 
Facial swelling, 
mean (SD), % 
Day 1 30.9 (1.6) ~ 30.9 (1.5) § 31.7 (1.6) 
Day 2 31.0 (1.6) II 31.2 (1.5) I 32.0 (1.5) 
Mouth-opening, 
mean (SD), % 
Day 1 36.0 (11.2) 38.8 (12.6) 39.2 (11.3) 
Day 2 38.1 (10.1) 38.1 (10.8) 36.0 (10.0) 
K = potassium. 
*P values were calculated using the 2-tailed t test. 
tp < 0.05 versus dexamethasone and acetaminophen and diclofenac K. 
*P = 0.013 versus diclofenac K. 
§P = 0.011 versus diclofenac K. 
II p = 0.002 versus diclofenac K. 
Ip = 0.004 versus diclofenac K. 
DISCUSSION 
In this study, the impact of drug combinations on pain, facial swelling, and tris- 
mus were assessed. By pharmacologically controlling the extent of the inflamma- 
tory process, the intensity of postoperative s quelae, such as pain, swelling, and 
trismus, may be reduced. 4,5 Regardless of drug combination, the pattern of post- 
operative pain has been reported to increase from postoperative days 1 to 3 and 
reduce gradually thereafter. 22-27 Our findings support his observation. Based on 
the literature search, many studies have compared the efficacy of NSAIDs and 
acetaminophen in controlling pain after oral surgery, 6,7,1H5 but none have com- 
pared the combination of dexamethasone and diclofenac K or acetaminophen. I  
the present study, dexamethasone was associated with augmentation of the 
analgesic potency of diclofenac K, suggesting that additional clinical benefit 
might be offered by adding dexamethasone to a regimen containing acetamino- 
phen or diclofenac K in the control of pain after third-molar extraction. 2,16,23,27,28 
Schultze-Mosgau et al, 28 in a prospective, randomized, controlled trial in 
40 (33 females, 7 males) patients (age range, 13-26 years) scheduled for third- 
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molar extraction, found that a combination of ibuprofen and methylpred- 
nisolone had good analgesic and anti-inflammatory action. The course of the 
swelling was assessed ultrasonically using a digital linear scanner, and pain was 
assessed using a visual analog scale. Results from randomized, controlled trials 
in adult patients undergoing oral surgery suggest hat single-dose administra- 
tion of a glucocorticoid (methylprednisolone) r duces tissue levels of brady- 
kinin and suppresses circulating levels of cortisol and [I-endorphin. 28 
Bradykinin and kallidin are the 2 kinins that act independently and synergisti- 
cally with products of arachidonic acid cascade to produce pain and increase 
vascular permeability. 29 Combination treatment with dexamethasone and 
NSAIDs has been found to have a positive effect on the arachidonic-acid cas- 
cade in the control of pain. 9,28,29 
The 4-point rating scale for pain intensity was used in this study because it 
is generally easily understood by patients. This method has been reported to 
be simple to administer, reliable, and valid. 6,21 
Postsurgical facial edema is difficult to quantify accurately because it 
requires 3 planes of measurement. Facial swelling is often irregular and can 
manifest internally or externally. Over the years, numerous researchers have 
tried various techniques to objectively measure dema. 14,16,22,28,29 Most are indi- 
rect assessments of the altered contours of the skin surface. Measurement tools 
mentioned in the literature include visual analog scales, trismus recordings, 
standardized stereo radiographic or photographic measurements, computed 
tomography, modified face bow devices, ultrasonography, and facial plethys- 
mographs. 14,16,22,28,29 In the present study, a single measurement from the tip of 
tragus to gonion to the tip of the contralateral tragus was taken. Cheek swelling 
after third-molar extraction was diffuse in different planes and difficult to mea- 
sure accurately. The concomitant administration of dexamethasone and diclo- 
fenac K was associated with a significant reduction compared with diclofenac K
monotherapy in postoperative facial swelling, suggesting that the efficacy of 
diclofenac K in the control of postoperative facial swelling is augmented by 
the addition of dexamethasone. Based on results from previous studies, the 
reduction, compared with diclofenac K monotherapy, in postoperative facial 
swelling in patients receiving concomitant therapy with dexamethasone and 
diclofenac K or acetaminophen was likely due to the anti-inflammatory effect 
of dexamethasone. 27,3°-34 
In the present study, the independent ( test) analysis did not find any statis- 
tically significant differences in trismus between the 3 treatment groups. 
Although this finding was contrary to previous reports in the literature, 22,25,28,34 
we observed a positive clinical association between dexamethasone and post- 
operative recovery of mouth-opening in third-molar extraction. 
Study Limitations 
There are no validated methods for the measurement of facial swelling. The 
technique adopted for measurement of facial swelling in this study has some 
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limitations. Facial swelling was measured in 1 dimension only, whereas it should 
be measured in 3 dimensions. Pain measurement is subjective and depends on 
the perception and pain threshold of the patient. The randomization method we 
used has not been validated. In addition, analysis of a third group comparing 
the effects of concomitant treatment with dexamethasone and acetaminophen 
with those of monotherapy with acetaminophen would have been beneficial. 
The objective of the present study was to measure the analgesic efficacy within 
the stated osing regimens. We considered that additional analgesics would dis- 
rupt the homogeneity of the outcome measures because only 2 of 155 patients 
required additional analgesics. Excluding 2 patients who required additional 
analgesia did not seem to bias the results. 
CONCLUSIONS 
In this small pilot study in patients undergoing third-molar extraction, concomi- 
tant administration of dexamethasone and diclofenac K was associated with 
better control of short-term postoperative pain and edema compared with 
monotherapy with diclofenac K. The results seem to suggest that the addition 
of dexamethasone to regimens containing diclofenac K or acetaminophen - 
hances the analgesic and anti-inflammatory effects of these 2 drugs. 
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